George J. Hruza, MD, President-Elect of the AAD

The American Academy of Dermatology (AAD) has elected new officers and board members, who took office following the academy’s annual meeting in March.

They include:

President...

Dupixent approved for atopic dermatitis

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic...

Valeant Pharmaceuticals International has closed its previously announced refinancing transactions. These include its offering of $1.25 billion aggregate principal amount of 6.50% senior secured...

Postmenopausal women with hirsutism are less likely to experience paradoxical hypertrichosis following treatment with an alexandrite laser if they snip their hair rather than shave it prior to...

New soft tissue filler approved

Allergan’s Juvéderm Vollure XC, known as Volift outside of the U.S., has received FDA marketing clearance for the correction of moderate to severe facial wrinkles and folds, such as nasolabial...

Image: four women with different aging concerns

At the 2017 American Academy of Dermatology (AAD) Annual Meeting—which boasted more than 18,800 attendees, including medical personnel, residents, fellows and students—nine speakers explored...